| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |